Pacira BioSciences (PCRX) Leases: 2019-2025
Historic Leases for Pacira BioSciences (PCRX) over the last 7 years, with Sep 2025 value amounting to $44.3 million.
- Pacira BioSciences' Leases fell 17.77% to $44.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year decrease of 17.77%. This contributed to the annual value of $49.2 million for FY2024, which is 19.33% down from last year.
- Per Pacira BioSciences' latest filing, its Leases stood at $44.3 million for Q3 2025, which was down 4.86% from $46.5 million recorded in Q2 2025.
- Pacira BioSciences' Leases' 5-year high stood at $76.4 million during Q4 2021, with a 5-year trough of $44.3 million in Q3 2025.
- Over the past 3 years, Pacira BioSciences' median Leases value was $56.3 million (recorded in 2024), while the average stood at $56.0 million.
- As far as peak fluctuations go, Pacira BioSciences' Leases soared by 93.78% in 2021, and later declined by 19.33% in 2024.
- Quarterly analysis of 5 years shows Pacira BioSciences' Leases stood at $76.4 million in 2021, then fell by 7.24% to $70.9 million in 2022, then decreased by 13.91% to $61.0 million in 2023, then decreased by 19.33% to $49.2 million in 2024, then declined by 17.77% to $44.3 million in 2025.
- Its Leases was $44.3 million in Q3 2025, compared to $46.5 million in Q2 2025 and $48.7 million in Q1 2025.